Since the discovery of the Rh blood group system in 1940, a greater understanding of
hemolytic disease of the fetus and newborn (HDFN) was gained. In the years thereafter …

Haemolytic disease of the foetus and newborn (HDFN) is most commonly due to red cell
alloimmunisation. In HDFN, maternal immunoglobulin antibodies directed against foetal red …

Hemolytic disease of the fetus and newborn (HDFN) affects 3/100 000 to 80/100 000
patients per year. It is due to maternal blood group antibodies that cause fetal red cell …

Red blood cell (RBC) sensitization occurs in some women in response to exposure to
paternally derived RBC antigens during pregnancy or to nonself antigens on transfused …

Haemolytic Disease of the Fetus and Newborn (HDFN) is caused by maternal
alloimmunization against red blood cell antigens. In severe cases, HDFN may lead to fetal …

Hemolytic disease of the newborn (HDN), also known as Erythroblastosis fetalis, is a
hemolytic condition that predominantly affects rhesus-positive fetuses and infants born to …

Hemolytic disease of the fetus and newborn (HDFN) is a potentially life-threatening illness of
neonates, caused by maternal-fetal red blood cell antigen incompatibilities. The clinical …

Hemolytic disease of the fetus and newborn (HDFN) is due to maternal alloantibodies
directed against paternally inherited antigens on fetal red cells, and it is still a problem in …

Rh hemolytic disease (HDN) is the prototype of maternal alloimmunization and fetal
hemolytic disease. There are other antigens capable of causing alloimmunization and …

Introduction: Hemolytic disease of the fetus and newborn (HDFN) occurs when fetal and
neonatal erythroid cells are destroyed by maternal erythrocyte alloantibodies, it leads to …